Literature DB >> 25373726

Cervical cancer-associated promoter polymorphism affects akna expression levels.

G A Martínez-Nava1, K Torres-Poveda1, A Lagunas-Martínez1, M Bahena-Román1, M A Zurita-Díaz1, E Ortíz-Flores1, A García-Carrancá2, V Madrid-Marina1, A I Burguete-García1.   

Abstract

Cervical cancer (CC) is responsible for >260,000 deaths worldwide each year. Efforts are being focused on identifying genetic susceptibility factors, especially in genes related to the immune response. Akna has been proposed to be one of them, but data regarding its functional role in the disease is scarce. Supporting the notion of akna as a CC susceptibility gene, we found two polymorphisms associated with squamous intraepithelial lesion (SIL) and CC; moreover, we identified an association between high akna expression levels and CC and SIL, but its direction differs in each disease stage. To show the potential existence of a cis-acting polymorphism, we assessed akna allelic expression imbalance for the alleles of the -1372C>A polymorphism. We found that, regardless of the study group, the number of transcripts derived from the A allele was significantly higher than those from the C allele. Our results support the hypothesis that akna is a CC susceptibility genetic factor and suggest that akna transcriptional regulation has a role in the disease. We anticipate our study to be a starting point for in vitro evaluation of akna transcriptional regulation and for the identification of transcription factors and cis-elements regulating AKNA function that are involved in carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25373726     DOI: 10.1038/gene.2014.60

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  50 in total

1.  dbSNP: the NCBI database of genetic variation.

Authors:  S T Sherry; M H Ward; M Kholodov; J Baker; L Phan; E M Smigielski; K Sirotkin
Journal:  Nucleic Acids Res       Date:  2001-01-01       Impact factor: 16.971

2.  CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help.

Authors:  R R French; H T Chan; A L Tutt; M J Glennie
Journal:  Nat Med       Date:  1999-05       Impact factor: 53.440

3.  Common fragile sites are conserved features of human and mouse chromosomes and relate to large active genes.

Authors:  Anne Helmrich; Karen Stout-Weider; Klaus Hermann; Evelin Schrock; Thomas Heiden
Journal:  Genome Res       Date:  2006-09-05       Impact factor: 9.043

4.  AKNA: another AT-hook transcription factor "hooking-up" with inflammation.

Authors:  Alison R Moliterno; Linda M S Resar
Journal:  Cell Res       Date:  2011-06-14       Impact factor: 25.617

5.  Aberrant expression of the myeloid zinc finger gene, MZF-1, is oncogenic.

Authors:  R Hromas; J Morris; K Cornetta; D Berebitsky; A Davidson; M Sha; G Sledge; F Rauscher
Journal:  Cancer Res       Date:  1995-08-15       Impact factor: 12.701

6.  The human AKNA gene expresses multiple transcripts and protein isoforms as a result of alternative promoter usage, splicing, and polyadenylation.

Authors:  Jennifer C Sims-Mourtada; Shirley Bruce; Morgan R McKeller; Roberto Rangel; Liliana Guzman-Rojas; Kelly Cain; Cristina Lopez; Drazen B Zimonjic; Nicholas C Popescu; John Gordon; Miles F Wilkinson; Hector Martinez-Valdez
Journal:  DNA Cell Biol       Date:  2005-05       Impact factor: 3.311

7.  An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV).

Authors:  P E Castle; S L Hillier; L K Rabe; A Hildesheim; R Herrero; M C Bratti; M E Sherman; R D Burk; A C Rodriguez; M Alfaro; M L Hutchinson; J Morales; M Schiffman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-10       Impact factor: 4.254

8.  Increased expression of the transcription factors CCAAT-enhancer binding protein-beta (C/EBBeta) and C/EBzeta (CHOP) correlate with invasiveness of human colorectal cancer.

Authors:  K Rask; M Thörn; F Pontén; W Kraaz; K Sundfeldt; L Hedin; S Enerbäck
Journal:  Int J Cancer       Date:  2000-05-01       Impact factor: 7.396

9.  CD3zeta expression and T cell proliferation are inhibited by TGF-beta1 and IL-10 in cervical cancer patients.

Authors:  Cinthya E Díaz-Benítez; Karla R Navarro-Fuentes; Jacqueline A Flores-Sosa; Janet Juárez-Díaz; Felipe J Uribe-Salas; Edgar Román-Basaure; Ludwig E González-Mena; Patricia Alonso de Ruíz; Guillermina López-Estrada; Alfredo Lagunas-Martínez; Victor H Bermúdez-Morales; Juan M Alcocer-González; Jesús Martínez-Barnetche; Rogelio Hernández-Pando; Yvonne Rosenstein; José Moreno; Vicente Madrid-Marina
Journal:  J Clin Immunol       Date:  2009-03-04       Impact factor: 8.317

10.  An integrated map of genetic variation from 1,092 human genomes.

Authors:  Goncalo R Abecasis; Adam Auton; Lisa D Brooks; Mark A DePristo; Richard M Durbin; Robert E Handsaker; Hyun Min Kang; Gabor T Marth; Gil A McVean
Journal:  Nature       Date:  2012-11-01       Impact factor: 49.962

View more
  3 in total

1.  HIF1A (rs11549465) and AKNA (rs10817595) Gene Polymorphisms Are Associated with Primary Sjögren's Syndrome.

Authors:  Gabriela Hernández-Molina; José Manuel Rodríguez-Pérez; Javier Fernández-Torres; Guadalupe Lima; Nonanzit Pérez-Hernández; Alberto López-Reyes; Gabriela Angélica Martínez-Nava
Journal:  Biomed Res Int       Date:  2017-04-06       Impact factor: 3.411

Review 2.  Functional Role of AKNA: A Scoping Review.

Authors:  Abrahán Ramírez-González; Joaquín Manzo-Merino; Carla Olbia Contreras-Ochoa; Margarita Bahena-Román; José Manasés Aguilar-Villaseñor; Alfredo Lagunas-Martínez; Yvonne Rosenstein; Vicente Madrid Marina; Kirvis Torres-Poveda
Journal:  Biomolecules       Date:  2021-11-17

3.  AKNA Is a Potential Prognostic Biomarker in Gastric Cancer and Function as a Tumor Suppressor by Modulating EMT-Related Pathways.

Authors:  Gang Wang; Dan Sun; Wenhui Li; Yan Xin
Journal:  Biomed Res Int       Date:  2020-05-13       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.